Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Medical Tech. Receives Approval for Cancer Drug Test

publication date: Nov 10, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Medical Technologies was granted approval by the SFDA for its real-time PCR-based Epidermal Growth Factor Receptor Assay. The EGFR PCR Assay is used to detect the 28 most common mutations in the EGFR gene in patients with non-small cell lung cancer, predicting the efficacy of targeted cancer drugs. EGFR abnormalities have been found in approximately 85% of NSCLC patients who responded to Iressa or Tarceva. More details....

Stock Symbol: (NSDQ: CMED)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners